# Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer

Source: https://onco.cc/trials/nct05395962/  
OnCo record `nct05395962` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Electrochemotherapy in Vulvar cancer, run by IRCCS Azienda Ospedaliero-Universitaria di Bologna, now recruiting.

## Summary

Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer is a phase 2 interventional study registered as NCT05395962 by IRCCS Azienda Ospedaliero-Universitaria di Bologna, with 92 participants planned, started 2022-04-08 and due to reach its primary completion in 2025-04-07. Interventions recorded: Carboplatin, Bleomycin. Conditions recorded: Vulvar Cancer.

Linked to the technology Electrochemotherapy because the registry's title names it ("electrochemotherapy") and Vulvar cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05395962
- Phase: 2
- Setting: Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer: the ElechtraPlatinum Study. A Randomized Controlled Trial
- Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrolled: 92

## Sources

- ClinicalTrials.gov NCT05395962: https://clinicaltrials.gov/study/NCT05395962

## Connected records

- cancers: [Vulvar cancer](https://onco.cc/cancers/vulvar/)
- technologies: [Electrochemotherapy](https://onco.cc/technologies/electrochemotherapy/)
- drugs: [Bleomycin](https://onco.cc/drugs/bleomycin/), [Carboplatin](https://onco.cc/drugs/carboplatin/)

---
JSON: https://onco.cc/api/v1/entities/nct05395962.json